SREBF2 and prostate carcinoma: A study comparing prostate cancer tissue with benign prostate tissue through single-cell sequencing revealed heightened activity in cholesterol metabolism and underscored the essential role of SREBP2 in prostate cancer progression (Wei et al., 2024).